Meningococcal vaccines in China [PDF]
Human Vaccines & Immunotherapeutics, 2021 Meningococcal meningitis caused by Neisseria meningitidis is a reportable infectious disease in China, due to the high incidence of meningitis in the era before the availability of vaccines.
Yinghua Xu +5 more
doaj +2 more sources
Exploring the Ability of Meningococcal Vaccines to Elicit Mucosal Immunity: Insights from Humans and Mice [PDF]
Pathogens, 2021 Neisseria meningitidis causes a devastating invasive disease but is also a normal colonizer of the human nasopharynx. Due to the rapid progression of disease, the best tool to protect individuals against meningococcal infections is immunization. Clinical
Elissa G. Currie, Scott D. Gray-Owen
doaj +2 more sources
Systematic literature review on the safety and immunogenicity of rotavirus vaccines when co-administered with meningococcal vaccines [PDF]
Human Vaccines & Immunotherapeutics, 2020 This study is aimed to review the published evidence on safety, immunogenicity, and efficacy of rotavirus vaccines when co-administered with meningococcal vaccines in infants. A systematic literature search was performed in four databases containing peer-
Priya Pereira +2 more
doaj +2 more sources
Concomitant administration of meningococcal vaccines with other vaccines in adolescents and adults: a review of available evidence [PDF]
Human Vaccines & Immunotherapeutics, 2019 Invasive meningococcal disease (IMD), a rapidly progressing and potentially fatal illness, disproportionately affects adolescents and young adults. While IMD is best prevented by vaccination, vaccine uptake in these groups is low.
Justine Alderfer +6 more
doaj +2 more sources
Suboptimal uptake of meningococcal vaccines among older adolescents: Barriers, solutions, and future research directions [PDF]
Human Vaccines & Immunotherapeutics, 2020 Over the past 15 y, several vaccines have been added to the recommended immunization schedule for adolescents in the United States. In addition to annual influenza vaccination, the Advisory Committee on Immunization Practices recommends tetanus ...
Linda M. Niccolai, Caitlin E. Hansen
doaj +2 more sources
Meningococcal vaccine evolution
Clinical Management Issues, 2012 Neisseria meningitidis is a leading cause of bacterial sepsis and meningitis worldwide. Although polysaccharide and glycoconjugate vaccines have been developed for serogroups A, C, Y and W-135, currently there are no broadly effective vaccines available ...
Gianni Bona, Carla Guidi
doaj +5 more sources
Meningococcal Vaccines: Current Status and Emerging Strategies
Vaccines, 2018 Neisseria meningitidis causes most cases of bacterial meningitis. Meningococcal meningitis is a public health burden to both developed and developing countries throughout the world.
Pumtiwitt C. McCarthy +2 more
doaj +2 more sources
Clonal analysis of meningococci during a 26 year period prior to the introduction of meningococcal serogroup C vaccines [PDF]
, 2015 Meningococcal disease remains a public health burden in the UK and elsewhere. Invasive Neisseria meningitidis, isolated in Scotland between 1972 and 1998, were characterised retrospectively to examine the serogroup and clonal structure of the circulating
Clarke, Stuart C. +3 more
core +19 more sources
Current status and challenges of meningococcal vaccines development in China
Zhongguo gonggong weisheng, 2022 Vaccination is the most effective and economical way to prevent meningococcal meningitis. In the past few decades, with widespread use of meningococcal vaccines, the incidence of meningococcal meningitis has dropped significantly. There are some vaccines
Ying-hua XU, Ya-nan LI, Qiang YE
doaj +1 more source
World Experience in the Use Serogroup B Meningococcal Vaccines (literature review)
Эпидемиология и вакцинопрофилактика, 2022 Relevance. The success of vaccine prophylaxis of meningococcal infection depends on the composition and properties of vaccine preparations and the strict implementation of recommendations on vaccine prophylaxis tactics by the territorial epidemiological ...
I. S. Koroleva, M. A. Koroleva
doaj +1 more source